Skip to search.
 TSX Up 0.60% TSX Ventures Up 1.02%

Neuralstem, Inc. (CUR)

-NasdaqCM
1.68 Down 0.05(2.89%) 11:09AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:1.73
Open:1.70
Bid:1.66 x 5400
Ask:1.67 x 300
1y Target Est:7.00
Beta:3.11
Earnings Date:Aug 6 - Aug 10 (Est.)
Day's Range:1.63 - 1.73
52wk Range:1.46 - 4.11
Volume:64,165
Avg Vol (3m):688,419
Market Cap:151.77M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
CURDown 2.89%151.77M
GERNUp 0.99%646.58M
STEMUp 1.02%43.64M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):8,888.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.26
Quarterly EPS Est (Jun-15) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of regenerative medicine treatments based on its human neuronal stem cells and small molecule compounds. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback